Literature DB >> 12023366

Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages.

Dawn M Flaherty1, Martha M Monick, A Brent Carter, Michael W Peterson, Gary W Hunninghake.   

Abstract

Alveolar macrophages have been implicated in the pathogenesis of a number of acute and chronic lung disorders. We have previously shown that normal human alveolar macrophages exhibit decreased DNA binding activity of the transcription factor, AP-1, compared with monocytes. Furthermore, this decrease in AP-1 DNA binding appears to be due to a decrease in the redox active protein, redox factor (Ref)-1. Ref-1 is an important redox regulator of a number of transcription factors, including NF-kappaB and AP-1. In this study we evaluated the role of asbestos, a prototypic model of chronic fibrotic lung disease, in Ref-1 expression and activity. We found that incubation with low concentrations of crocidolite asbestos (0.5-1.25 microg/cm(2)) resulted in an increase in nuclear Ref-1 protein after 5 min, with a persistent elevation in protein up to 24 h. Additionally, an increase in nuclear Ref-1 could be induced by treating the cells with an oxidant-generating stimulus (iron loading plus PMA) and inhibited by diphenyleneiodonium chloride, an inhibitor of NADPH oxidase. The asbestos-induced accumulation of nuclear Ref-1 was associated with an increase in AP-1 DNA binding activity. These findings suggest that an exposure associated with fibrotic lung disease, i.e., asbestos, modulates accumulation of nuclear Ref-1 in macrophages, and that this effect is mediated by an oxidant stimulus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023366     DOI: 10.4049/jimmunol.168.11.5675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons.

Authors:  Yanlin Jiang; Chunlu Guo; Michael R Vasko; Mark R Kelley
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 2.  Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment.

Authors:  Gianluca Tell; Damiano Fantini; Franco Quadrifoglio
Journal:  Cell Mol Life Sci       Date:  2010-08-13       Impact factor: 9.261

3.  15-deoxy-Delta12,14-prostaglandin J2 impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase.

Authors:  Alan J Ryan; Bill B Chen; Prashanth R Vennalaganti; Florita C Henderson; Linda A Tephly; A Brent Carter; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2008-07-08       Impact factor: 5.157

4.  Extracellular vesicles deliver Mycobacterium RNA to promote host immunity and bacterial killing.

Authors:  Yong Cheng; Jeffery S Schorey
Journal:  EMBO Rep       Date:  2019-01-25       Impact factor: 8.807

5.  The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung.

Authors:  Catrin Albrecht; Ad M Knaapen; Andrea Becker; Doris Höhr; Petra Haberzettl; Frederik J van Schooten; Paul J A Borm; Roel P F Schins
Journal:  Respir Res       Date:  2005-11-02

6.  Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310.

Authors:  Jing Qu; Guang-Hui Liu; Bo Huang; Chang Chen
Journal:  Nucleic Acids Res       Date:  2007-04-01       Impact factor: 16.971

7.  Human AP endonuclease suppresses DNA mismatch repair activity leading to microsatellite instability.

Authors:  In-Youb Chang; Soo-Hyun Kim; Hyun-Ju Cho; Do Young Lee; Mi-Hwa Kim; Myung-Hee Chung; Ho Jin You
Journal:  Nucleic Acids Res       Date:  2005-09-07       Impact factor: 16.971

8.  A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity.

Authors:  Kozue Ando; Satoshi Hirao; Yasuaki Kabe; Yuji Ogura; Iwao Sato; Yuki Yamaguchi; Tadashi Wada; Hiroshi Handa
Journal:  Nucleic Acids Res       Date:  2008-06-27       Impact factor: 16.971

Review 9.  Low Reactive Level Laser Therapy for Mesenchymal Stromal Cells Therapies.

Authors:  Toshihiro Kushibiki; Takeshi Hirasawa; Shinpei Okawa; Miya Ishihara
Journal:  Stem Cells Int       Date:  2015-07-26       Impact factor: 5.443

10.  Photodynamic activation as a molecular switch to promote osteoblast cell differentiation via AP-1 activation.

Authors:  Toshihiro Kushibiki; Yupeng Tu; Adnan O Abu-Yousif; Tayyaba Hasan
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.